A detailed history of Strategic Asset Management, LLC transactions in Invitae Corp stock. As of the latest transaction made, Strategic Asset Management, LLC holds 5,000 shares of NVTA stock, worth $0. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,000
Previous 4,300 16.28%
Holding current value
$0
Previous $10,000 20.0%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022

BUY
$1.9 - $8.63 $1,330 - $6,041
700 Added 16.28%
5,000 $12,000
Q2 2022

Jul 14, 2022

BUY
$2.13 - $9.01 $2,130 - $9,010
1,000 Added 30.3%
4,300 $10,000
Q1 2022

Apr 20, 2022

BUY
$6.28 - $15.59 $4,396 - $10,913
700 Added 26.92%
3,300 $26,000
Q4 2021

Jan 26, 2022

BUY
$14.7 - $28.67 $4,410 - $8,601
300 Added 13.04%
2,600 $40,000
Q3 2021

Nov 04, 2021

BUY
$24.31 - $33.6 $55,913 - $77,280
2,300 New
2,300 $61,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Strategic Asset Management, LLC Portfolio

Follow Strategic Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Asset Management, LLC with notifications on news.